PTC Therapeutics | PTCT - Trade Debtors


PTC Therapeutics reported $181.62M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Acadia Pharmaceuticals USD 148.23M 8.79M Dec/2025
Alnylam Pharmaceuticals USD 777.57M 187.2M Dec/2025
Amgen USD 9.57B 1.08B Dec/2025
BioCryst Pharmaceuticals USD 106.82M 15.49M Dec/2025
Biogen USD 1.85B 234M Sep/2025
BioMarin Pharmaceutical USD 908.21M 117.95M Dec/2025
Cytokinetics USD 1.81M 6.6M Sep/2025
Daiichi Sankyo JPY 695.95B 79.1B Dec/2025
Enanta Pharmaceuticals USD 40.16M 1.52M Dec/2024
Esperion Therapeutics USD 140.19M 21.21M Dec/2025
Gilead Sciences USD 4.91B 182M Dec/2025
Incyte USD 1.02B 128.52M Dec/2025
Ionis Pharmaceuticals USD 66M 41.39M Dec/2025
Ironwood Pharmaceuticals USD 81.89M 5.68M Dec/2024
Karyopharm Therapeutics USD 31.78M 6.82M Sep/2024
Novartis USD 8.98B 192M Sep/2025
Pfizer USD 18.12B 2.02B Sep/2025
PTC Therapeutics USD 181.62M 21.45M Dec/2025
Puma Biotechnology USD 28.1M 3.52M Jun/2024
Roche Holding CHF 11.9B 460M Dec/2025
Sangamo BioSciences USD 581K 110K Jun/2024
Sarepta Therapeutics USD 398.23M 2.49M Dec/2025
TG Therapeutics USD 265.38M 33.86M Sep/2025
Ultragenyx Pharmaceutical USD 112.54M 11.92M Sep/2025
Vertex Pharmaceuticals USD 2.05B 106.4M Dec/2025
Xencor USD 29.3M 7.49M Dec/2025